Journal Home
Search for

Volume 228, Issue 1, Pages 65-69 (18 October 2005)


View previous. 13 of 43 View next.

Oligogenic inheritance in neuroblastoma

Luca Longoa, Gian Paolo Toninia, Isabella Ceccherinib, Patrizia PerricCorresponding Author Informationemail address

Received 22 November 2004; accepted 2 December 2004.

Abstract 

Neuroblastoma (NB), a childhood malignancy affecting neural crest deriving cell lineages, is characterized by great clinical variability and histological heterogeneity.

As NB usually occurs as sporadic form, molecular studies were mainly carried out on tumor samples and derived cell lines, leading to the identification of several somatic alterations. Although familial NB is rare, linkage data obtained from different families have provided evidence of linkage to markers mapping to different chromosomal regions, indicating a remarkable genetic heterogeneity of NB. The first evidence of germline mutations in NB pedigrees has been recently reported in the paired-like homeobox 2B (PHOX2B) gene, involved in the development of neural crest deriving cells. Nevertheless, as only a few NB families but not others have been shown to carry PHOX2B mutations, the role of this gene in NB predisposition has still to be clarified.

On the basis of the current data, familial NB cannot be modeled as a Mendelian monogenic trait. Instead, an oligogenic mode of inheritance might explain the existence of different NB loci genetically interacting to cause and/or modify the disease-phenotype.

a Paediatric Translational Oncology, National Institute for Cancer Research (IST), Genoa, Italy

b Laboratory of Molecular Genetics, G. Gaslini Institute, Genoa, Italy

c Laboratory of Neuroblastoma Research, Fondazione Italiana per la Lotta al Neuroblastoma c/o Advanced Biotechnology Center (CBA), Genoa, L.go R. Benzi, 10, 16132, Italy

Corresponding Author InformationCorresponding author. Tel.: +39 010 57 37 430; fax: +39 010 57 37 463.

PII: S0304-3835(05)00340-X

doi:10.1016/j.canlet.2004.12.052


View previous. 13 of 43 View next.